Correlation Between Protara Therapeutics and Vaccibody

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Vaccibody at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Vaccibody into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Vaccibody As, you can compare the effects of market volatilities on Protara Therapeutics and Vaccibody and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Vaccibody. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Vaccibody.

Diversification Opportunities for Protara Therapeutics and Vaccibody

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Protara and Vaccibody is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Vaccibody As in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccibody As and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Vaccibody. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccibody As has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Vaccibody go up and down completely randomly.

Pair Corralation between Protara Therapeutics and Vaccibody

If you would invest (100.00) in Vaccibody As on December 30, 2024 and sell it today you would earn a total of  100.00  from holding Vaccibody As or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Protara Therapeutics  vs.  Vaccibody As

 Performance 
       Timeline  
Protara Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Protara Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Vaccibody As 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaccibody As has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Vaccibody is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Protara Therapeutics and Vaccibody Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protara Therapeutics and Vaccibody

The main advantage of trading using opposite Protara Therapeutics and Vaccibody positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Vaccibody can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccibody will offset losses from the drop in Vaccibody's long position.
The idea behind Protara Therapeutics and Vaccibody As pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio